Similar articles

• [Cancer immunotherapy with BCG and its derivatives--clinical trials (author's transl)].

  Ogura T. Ogura T. Kekkaku. 1980 Aug;55(8):359-63. Kekkaku. 1980. PMID: 6999203 Review. Japanese. No abstract available.
• BCG in tumor immunotherapy.

  Baldwin RW, Pimm MV. Baldwin RW, et al. Adv Cancer Res. 1978;28:91-147. doi: 10.1016/s0065-230x(08)60647-8. Adv Cancer Res. 1978. PMID: 360797 Review. No abstract available.
• Hepatic granulomas and other hepatic lesions associated with BCG immunotherapy for cancer.

  Bodurtha A, Kim YH, Laucius JF, Donato RA, Mastrangelo MJ. Bodurtha A, et al. Am J Clin Pathol. 1974 Jun;61(6):747-52. doi: 10.1093/ajcp/61.6.747. Am J Clin Pathol. 1974. PMID: 4598826 No abstract available.
• [Effect of intra-tumoral injection of tuberculin-active protein on growth of transplantable mouse melanomas].

  Saida T. Saida T. Nihon Hifuka Gakkai Zasshi. 1982 Nov;92(13):1389-98. Nihon Hifuka Gakkai Zasshi. 1982. PMID: 6984864 Japanese. No abstract available.
• BCG and cancer.

  Bast RC Jr, Zbar B, Borsos T, Rapp HJ. Bast RC Jr, et al. N Engl J Med. 1974 Jun 27;290(26):1458-69. doi: 10.1056/NEJM197406272902605. N Engl J Med. 1974. PMID: 4598691 Review. No abstract available.